Author Affiliations: Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois (email@example.com).
To the Editor: Dr Giuliano and colleagues concluded that sentinel lymph node (SLN) biopsy alone is not inferior to ALND in patients with T1-T2 breast cancer and limited SLN involvement treated with breast conservation and adjuvant systemic therapy.1 Variable radiation techniques may have had an impact on the results and interpretation of this trial.
Hasselle MD, Dorn PL. Axillary vs Sentinel Lymph Node Dissection for Invasive Breast Cancer. JAMA. 2011;305(22):2288-2291. doi:10.1001/jama.2011.752